418 | CIRCULATING TUMOR DNA ASSESSMENT IN PATIENTS WITH EARLY‐STAGE CLASSICAL HODGKIN LYMPHOMA TREATED WITH COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB | Publicación